As we continue to learn more about optimizing nutrition for individuals on semaglutide, tirzepatide, and other GLP-1 drugs, the importance of comprehensive care that addresses not just weight loss, but overall digestive wellness, becomes increasingly clear
We kept the animals in the animal experiment center (SPF-grade) of Huazhong University of science and technology (22C2C, 12 h light/dark cycles, 40%60% humidity)
Harach T, Pols TWH, Nomura M, Maida A, Watanabe M, Auwerx J, et al
The relationship between GLP-1 receptor agonists and generalized skin sensitivity remains unclear, as there is no official established link between these medications and widespread sensitive skin as a direct pharmacological effect
Not willing to give up, Holst turned to Thue Schwartz, a young Danish medical student and molecular pharmacologist working with Rehfeld on gastrin and new peptides isolated from the pancreas
Study procedure (Koide et al., 2025) GLP-1RA therapy significantly reduced blood glucose levels, body weight, and body fat percentage Results showed that after 12 months of treatment, GLP-1RA therapy significantly reduced participants blood glucose levels (as measured by glycated hemoglobin), body weight, and body fat percentage